{"disease":{"id":"asthma-with-eosinophilic-phenotype","name":"asthma with eosinophilic phenotype"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05384938","title":"FAsenra Safety Trial in India","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05522439","title":"A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}